272 related articles for article (PubMed ID: 33971969)
1. Antimicrobial susceptibility testing results from 13 hospitals in Viet Nam: VINARES 2016-2017.
Vu TVD; Choisy M; Do TTN; Nguyen VMH; Campbell JI; Le TH; Nguyen VT; Wertheim HFL; Pham NT; Nguyen VK; van Doorn HR;
Antimicrob Resist Infect Control; 2021 May; 10(1):78. PubMed ID: 33971969
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility testing and antibiotic consumption results from 16 hospitals in Viet Nam: The VINARES project 2012-2013.
Vu TVD; Do TTN; Rydell U; Nilsson LE; Olson L; Larsson M; Hanberger H; Choisy M; Dao TT; van Doorn HR; Nguyen VK; Nguyen VT; Wertheim HFL;
J Glob Antimicrob Resist; 2019 Sep; 18():269-278. PubMed ID: 31201995
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial.
Morfin-Otero R; Noriega ER; Dowzicky MJ
Ann Clin Microbiol Antimicrob; 2015 Dec; 14():53. PubMed ID: 26667651
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.
Vega S; Dowzicky MJ
Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):50. PubMed ID: 28701170
[TBL] [Abstract][Full Text] [Related]
5. Eight-year trends in the relative isolation frequency and antimicrobial susceptibility among bloodstream isolates from Greek hospitals: data from the Greek Electronic System for the Surveillance of Antimicrobial Resistance - WHONET-Greece, 2010 to 2017.
Polemis M; Tryfinopoulou K; Giakkoupi P; ; Vatopoulos A
Euro Surveill; 2020 Aug; 25(34):. PubMed ID: 32856583
[TBL] [Abstract][Full Text] [Related]
6. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ
Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Zhanel GG; DeCorby M; Laing N; Weshnoweski B; Vashisht R; Tailor F; Nichol KA; Wierzbowski A; Baudry PJ; Karlowsky JA; Lagacé-Wiens P; Walkty A; McCracken M; Mulvey MR; Johnson J; ; Hoban DJ
Antimicrob Agents Chemother; 2008 Apr; 52(4):1430-7. PubMed ID: 18285482
[TBL] [Abstract][Full Text] [Related]
8. Patterns of Drug-Resistant Bacteria in a General Hospital, China, 2011-2016.
Mao T; Zhai H; Duan G; Yang H
Pol J Microbiol; 2019; 68(2):225-232. PubMed ID: 31250593
[TBL] [Abstract][Full Text] [Related]
9. Trends in the susceptibility of clinically important resistant bacteria to tigecycline: results from the Tigecycline In Vitro Surveillance in Taiwan study, 2006 to 2010.
Chen YH; Lu PL; Huang CH; Liao CH; Lu CT; Chuang YC; Tsao SM; Chen YS; Liu YC; Chen WY; Jang TN; Lin HC; Chen CM; Shi ZY; Pan SC; Yang JL; Kung HC; Liu CE; Cheng YJ; Liu JW; Sun W; Wang LS; Ko WC; Yu KW; Chiang PC; Lee MH; Lee CM; Hsu GJ; Hsueh PR
Antimicrob Agents Chemother; 2012 Mar; 56(3):1452-7. PubMed ID: 22203598
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial.
Zhang Z; Chen M; Yu Y; Pan S; Liu Y
Antimicrob Resist Infect Control; 2018; 7():152. PubMed ID: 30564308
[TBL] [Abstract][Full Text] [Related]
11. [Surveillance of bacterial resistance in children aged 0-14 years from 2018 to 2022].
China Antimicrobial Resistance Surveillance System
Zhonghua Er Ke Za Zhi; 2023 Nov; 61(11):1001-1010. PubMed ID: 37855078
[No Abstract] [Full Text] [Related]
12. Frequency of isolation and antimicrobial resistance of gram-negative and gram-positive bacteria from patients in intensive care units of 25 European university hospitals participating in the European arm of the SENTRY Antimicrobial Surveillance Program 1997-1998.
Fluit AC; Verhoef J; Schmitz FJ;
Eur J Clin Microbiol Infect Dis; 2001 Sep; 20(9):617-25. PubMed ID: 11714042
[TBL] [Abstract][Full Text] [Related]
13. Bacterial susceptibility in bloodstream infections: Results from China Antimicrobial Resistance Surveillance Trial (CARST) Program, 2015-2016.
Zhang F; Li Y; Lv Y; Zheng B; Xue F
J Glob Antimicrob Resist; 2019 Jun; 17():276-282. PubMed ID: 30611932
[TBL] [Abstract][Full Text] [Related]
14. Increasing Resistance to Extended-Spectrum Cephalosporins, Fluoroquinolone, and Carbapenem in Gram-Negative Bacilli and the Emergence of Carbapenem Non-Susceptibility in Klebsiella pneumoniae: Analysis of Korean Antimicrobial Resistance Monitoring System (KARMS) Data From 2013 to 2015.
Kim D; Ahn JY; Lee CH; Jang SJ; Lee H; Yong D; Jeong SH; Lee K
Ann Lab Med; 2017 May; 37(3):231-239. PubMed ID: 28224769
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of Gram-negative and Gram-positive bacteria collected from Eastern Europe: Results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.), 2011-2016.
Dowzicky MJ; Chmelařová E
J Glob Antimicrob Resist; 2019 Jun; 17():44-52. PubMed ID: 30445209
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of ceftaroline, ceftazidime-avibactam, and comparators against Gram-positive and -negative organisms in China: the 2018 results from the ATLAS program.
Jia P; Zhu Y; Zhang H; Cheng B; Guo P; Xu Y; Yang Q
BMC Microbiol; 2022 Oct; 22(1):234. PubMed ID: 36182895
[TBL] [Abstract][Full Text] [Related]
17. Bacterial distribution and drug resistance in blood samples of children in Jiangxi Region, 2017-2021.
Zhou Y; Zhou S; Peng J; Min L; Chen Q; Ke J
Front Cell Infect Microbiol; 2023; 13():1163312. PubMed ID: 37424793
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of gram-negative and gram-positive bacteria collected from countries in Eastern Europe: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2004-2010.
Balode A; Punda-Polić V; Dowzicky MJ
Int J Antimicrob Agents; 2013 Jun; 41(6):527-35. PubMed ID: 23590898
[TBL] [Abstract][Full Text] [Related]
19. Bacterial etiology and antimicrobial resistance pattern of pediatric bloodstream infections: a 5-year experience in an Iranian referral hospital.
Sajedi Moghaddam S; Mamishi S; Pourakbari B; Mahmoudi S
BMC Infect Dis; 2024 Apr; 24(1):373. PubMed ID: 38565980
[TBL] [Abstract][Full Text] [Related]
20. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
Dowzicky MJ; Park CH
Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]